Promega's Política de cookies

Empleamos cookies y tecnologías similares para mantener la funcionalidad de nuestro sitio web, analizar su rendimiento, mejorar el funcionamiento y mostrar contenido personalizado. Algunas cookies son esenciales para el buen funcionamiento de nuestro sitio web. El resto no serán instaladas en su equipo sin su consentimiento. Visite la Política de Cookies para obtener mayor detalle.

ccfDNA 101: Emerging Trends in Oncology Research

  • What is ccfDNA?
  • How do laboratories commonly extract ccfDNA?
  • What are typical applications for ccfDNA?

Summary

ccfDNA Webinar Series: The Basics and Beyond
Part 1 - ccfDNA 101: Emerging Trends in Oncology Research

Circulating cell-free DNA (ccfDNA) found in plasma and other bodily fluids shows great promise as a source of easily accessible DNA-based information.  Research is giving rise to the possibility of liquid biopsies that would eliminate the need for invasive tissue collection.

In this webinar, we will discuss ccfDNA in relation to the other molecules commonly referred to as liquid biopsy. When working with ccfDNA there are many considerations and we will discuss factors for sample collection from blood, expected recovery (yields) of ccfDNA and thoughts on the detection of rare events given expected yields and the frequency of mutational events vs. the sensitivity of various downstream assays.

Don't forget to check out Part 2 & 3!

 


Speaker

doug-white-125x126

Douglas White
Research Scientist
Promega Corporation

Doug White graduated from University of Wisconsin Madison with a Master’s Degree in Biochemistry and has been a Promega scientist for 25 years. While at Promega, he’s developed multiple key products including PepTag®, IsoQuant®, PureYield™ Midi and Maxipreps, and various ReliaPrep™ Nucleic Acid Purification Kits.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up